MICA-STR A.4 is associated with slower hearing loss progression in patients with Ménière's disease

Otology and Neurotology

Volumn 33, Issue 2, 2012, Pages 223-229

  Gazquez, Irene ^a,b   Moreno, Antonia ^b   Aran, Ismael ^c   Soto Varela, Andres ^d   Santos, Sofia ^d   Perez Garrigues, Herminio ^e   Lopez Nevot, Alicia ^f   Requena, Teresa ^a   Lopez Nevot, Miguel Angel ^b   Lopez Escamez, Jose Antonio ^a,f  

^a PTS Granada   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^c Hospital de Pontevedra   (Spain)

^d University Hospital of Santiago de Compostela   (Spain)

^e HOSPITAL UNIVERSITARIO LA FE   (Spain)

^f HOSPITAL DE PONIENTE   (Spain)

Author keywords

Human leukocyte antigen; MICA gene; Microsatellite polymorphism; Vertigo

Indexed keywords

DNA; HLA ANTIGEN; HLA ANTIGEN CLASS 1; MHC CLASS I RELATED CHAIN A; MHC CLASS I-RELATED CHAIN A; PRIMER DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHILD; DISEASE COURSE; EXON; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETICS; GENOTYPE; HEARING LOSS; HETEROZYGOTE; HUMAN; KAPLAN MEIER METHOD; MALE; MENIERE DISEASE; MIDDLE AGED; ONSET AGE; POLYMERASE CHAIN REACTION; RECURRENT DISEASE; SPAIN; SURVIVAL;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; DISEASE PROGRESSION; DNA; DNA PRIMERS; EXONS; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HEARING LOSS; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; KAPLAN-MEIER ESTIMATE; LINKAGE DISEQUILIBRIUM; MALE; MENIERE DISEASE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECURRENCE; SPAIN; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84855986843     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e31824296c8     Document Type: Article

References (29)

1. Gottschlich S, Billings PB, Keithley EM, Weisman MH, Harris JP. Assessment of serum antibodies in patients with rapidly progressive sensorineural hearing loss and Menière's disease. Laryngoscope 1995;105:1347-52.
2. Brookes GB. Circulating immune complexes in Meniere's disease. Arch Otolaryngol Head Neck Surg 1986;112:536-40. (Pubitemid 16043961)
3. Ruckenstein MJ, Prasthoffer A, Bigelow DC, Von Feldt JM, Kolasinski SL. Immunologic and serologic testing in patients with Ménière's disease. Otol Neurotol 2002;23:517-20; discussion 520-1. (Pubitemid 34774042)
4. Balsa A, Cabezón A, Orozco G, et al. Influence of HLA DRB1 alleles in the susceptibility of rheumatoid arthritis and the regulation of antibodies against citrullinated proteins and rheumatoid factor. Arthritis Res Ther 2010;12:R62.
5. Handunnetthi L, Ramagopalan SV, Ebers GC, Knight JC. Regulation of major histocompatibility complex class II gene expression, genetic variation and disease. Genes Immun 2010;11:99-112.
6. International MHC and Autoimmunity Genetics Network, Rioux JD, Goyette P, Vyse TJ, et al. Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases. Proc Natl Acad Sci U S A 2009;106:18680-5.
7. Bergamaschi L, Leone MA, Fasano ME, et al. HLA-class I markers and multiple sclerosis susceptibility in the Italian population. Genes Immun 2010;11:173-80.
8. Rawal SG, Thakkar KH, Ziai K, Santi PA, Djalilian HR. HLA-B27-associated bilateral Ménière disease. Ear Nose Throat J 2010;89: 122-7.
9. Yeo SW, Park SN, Jeon EJ, Lee HY, Pyo CW, Kim TG. Influence of human leukocyte antigen in the pathogenesis of Ménière's disease in the South Korean population. Acta Otolaryngol 2002;122: 851-6. (Pubitemid 36132456)
10. Melchiorri L, Martini A, Rizzo R, Berto A, Adinolfi E, Baricord OR. Human leukocyte antigen-A,-B,-C and-DR alleles and soluble human leukocyte antigen class I serum level in Ménière's disease. Acta Otolaryngol Suppl 2002;548:26-9. (Pubitemid 34913450)
11. Koyama S, Mitsuishi Y, Bibee K, Watanabe I, Terasaki PI. HLA associations with Menieres disease. Acta Otolaryngol 2002;258: 347-50.
12. Lopez-Escamez JA, Vilchez JR, Soto-Varela A, et al. HLADRB1* 1101 allele may be associated with bilateral Méniére's disease in southern European population. Otol Neurotol 2007;28: 891-5. (Pubitemid 47511562)
13. Bahram S, Bresnahan M, Geraghty DE, Spies T. A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci U S A 1994;91:6259-63. (Pubitemid 24200639)
14. Bahram S, Mizuki N, Inoko H, Spies T. Nucleotide sequence of the human MHC class I MICA gene. Immunogenetics 1996;44:80-1. (Pubitemid 26131489)
15. Bauer S, Groh V, Wu J, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999;285: 727-9.
16. Rueda B, Pascual M, López-Nevot MA, et al. Association of MICA-A5.1 allele with susceptibility to celiac disease in a family study. Am J Gastroenterol 2003;98:359-62. (Pubitemid 36232386)
17. Gambelunghe G, Gerli R, Bocci EB, et al. Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus. Rheumatology (Oxford) 2005;44:287-92. (Pubitemid 40361282)
18. López-Hernández R, Valdés M, Lucas D, et al. Association analysis of MICA gene polymorphism and MICA-129 dimorphism with inflammatory bowel disease susceptibility in a Spanish population. Hum Immunol 2010;71:512-4.
19. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. American Academy of OtolaryngologyYHead and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995;113:181-5.
20. Ota M, Katsuyama Y, Mizuki N, et al. Trinucleotide repeat polymorphism within exón 5 of the MICA gene (MHC class I chainrelated gene A): allele frequency data in the nine population groups Japanese, Northern Han, Hui, Uygur, Kazakhstan, Iranian, Saudi Arabian, Greek an Italian. Tissue Antigens 1997;49:448-54. (Pubitemid 27207749)
21. Tabor HK, Risch NJ, Myers RM. Candidate-gene approaches for studying complex genetic traits: Practical considerations. Nat Rev Genet 2002;3:91-397.
22. Tian W, Li X-L, Wang F, et al. MICA-STR, HLA-B haplotypic diversity and linkage disequilibrium in the Hunan Han population of southern China. Int J Immunogenet 2006;33:241-5. (Pubitemid 44086963)
23. Choy MK, Phipps ME. MICA polymorphism: biology and importance in immunity and disease. Trends Mol Med 2010;16: 97-106.
24. Steinle A, Li P, Morris DL, et al. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family. Immunogenetics 2001;53:279-87. (Pubitemid 32678762)
25. Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR, Spies T. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2001;2:255-60. (Pubitemid 33706003)
26. Caillat-Zucman S. How NKG2D ligands trigger autoimmunity? Hum Immunol 2006;67:204-7. (Pubitemid 43673924)
27. Fdez-Morera JL, Rodrigo L, López-Vázquez A, et al. MHC class I chain-related gene A transmembrane polymorphism modulates the extensión of ulcerative colitis. Hum Immunol 2003;64:816-22. (Pubitemid 36927646)
28. Gambelunghe G, Ghanderi M, Cosentino A, et al. Association of MHC class I chain-related A (MIC-A) gene polymorphism with type I diabetes. Diabetologia 2000;43:507-14. (Pubitemid 30237961)
29. Fdez Morera JL, Tunon A, Rodriguez-Rodero S, et al. Clinical behavior of multiple sclerosis in modulated by the MHC class I chain-related gene A. Tissue Antigens 2006;67:409-14.